Salbutamol Completed Phase 2 Trials for Lung Diseases, Obstructive Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT00117182Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD